IRIS
BIANCHI, MARZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.736
EU - Europa 6.345
AS - Asia 3.861
SA - Sud America 327
AF - Africa 64
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 7
Totale 21.367
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.585
GB - Regno Unito 2.394
CN - Cina 1.851
SG - Singapore 1.047
UA - Ucraina 826
IT - Italia 798
SE - Svezia 486
RU - Federazione Russa 434
DE - Germania 404
FI - Finlandia 399
TR - Turchia 340
BR - Brasile 265
VN - Vietnam 195
IE - Irlanda 185
FR - Francia 176
IN - India 104
CA - Canada 97
JP - Giappone 64
KR - Corea 48
PL - Polonia 47
BE - Belgio 44
HK - Hong Kong 44
MX - Messico 43
PK - Pakistan 31
NL - Olanda 29
BD - Bangladesh 27
ES - Italia 26
AR - Argentina 25
ZA - Sudafrica 20
AU - Australia 18
CZ - Repubblica Ceca 18
IQ - Iraq 18
AT - Austria 15
LT - Lituania 15
MA - Marocco 11
RO - Romania 11
IR - Iran 10
VE - Venezuela 10
EG - Egitto 9
ID - Indonesia 9
NZ - Nuova Zelanda 9
SA - Arabia Saudita 9
TG - Togo 9
AE - Emirati Arabi Uniti 8
IL - Israele 7
JO - Giordania 7
CL - Cile 6
EC - Ecuador 5
EU - Europa 5
HU - Ungheria 5
KG - Kirghizistan 5
PT - Portogallo 5
PY - Paraguay 5
SK - Slovacchia (Repubblica Slovacca) 5
BG - Bulgaria 4
CO - Colombia 4
JM - Giamaica 4
NP - Nepal 4
PH - Filippine 4
TW - Taiwan 4
UZ - Uzbekistan 4
AZ - Azerbaigian 3
BH - Bahrain 3
CR - Costa Rica 3
DZ - Algeria 3
KE - Kenya 3
KZ - Kazakistan 3
LV - Lettonia 3
NO - Norvegia 3
PE - Perù 3
QA - Qatar 3
TN - Tunisia 3
BO - Bolivia 2
CH - Svizzera 2
DK - Danimarca 2
GR - Grecia 2
IM - Isola di Man 2
LA - Repubblica Popolare Democratica del Laos 2
MY - Malesia 2
PA - Panama 2
RS - Serbia 2
TH - Thailandia 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
LU - Lussemburgo 1
MK - Macedonia 1
MU - Mauritius 1
NG - Nigeria 1
RE - Reunion 1
SI - Slovenia 1
SV - El Salvador 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 21.367
Salva come PNG Salva come JPEG
Città #
Southend 2.147
Ashburn 1.266
Woodbridge 1.177
Fairfield 1.141
Houston 750
Ann Arbor 736
Jacksonville 659
Singapore 548
Chandler 506
Seattle 488
Cambridge 455
San Jose 436
Wilmington 393
Nanjing 326
Beijing 294
Dallas 286
Izmir 247
Boardman 199
Helsinki 192
Dublin 183
Urbino 140
Los Angeles 134
Nanchang 130
New York 118
Lauterbourg 98
Munich 98
Princeton 96
San Mateo 94
Düsseldorf 86
Shenyang 82
Hebei 65
Changsha 63
Tianjin 54
Ho Chi Minh City 52
Bremen 50
Jiaxing 50
Istanbul 49
Santa Clara 47
Brussels 43
Buffalo 42
Council Bluffs 42
Hong Kong 41
Frankfurt am Main 40
Tokyo 40
San Diego 39
São Paulo 38
Moscow 37
Shanghai 37
Jinan 36
London 35
Hanoi 33
Kunming 32
Montreal 31
Mülheim 31
San Francisco 30
Warsaw 29
Chennai 28
Denver 28
Poplar 28
Hangzhou 27
Toronto 27
Zhengzhou 27
Guangzhou 26
Orem 26
Seongnam 26
Velikiy Novgorod 26
Turku 25
Dong Ket 24
Ottawa 24
Atlanta 20
Chicago 20
Ningbo 20
Stockholm 20
The Dalles 19
Des Moines 18
Mexico City 16
Bologna 15
Brooklyn 15
Rawalpindi 15
Venice 15
Brno 14
Macerata 14
Mumbai 14
Pesaro 14
Rome 14
Seoul 14
Norwalk 13
Redwood City 13
Agugliano 12
Ascoli Piceno 12
Kraków 12
Lanzhou 12
Ancona 11
Boston 11
Changchun 11
Manchester 11
Taizhou 11
Wuppertal 11
Milan 10
Nuremberg 10
Totale 15.370
Salva come PNG Salva come JPEG
Nome #
Yin Yang 1 intronic binding sequences and splicing elicit intron-mediated enhancement of ubiquitin C gene expression 453
Stochastic modelling of PTEN regulation in brain tumors: a model for Glioblastoma Multiforme 443
Covalent functionalization of SWCNTs with ODNs targeting NF-kB: toward the construction of cell-penetrating decoy molecoles. 386
Molecular Dissection of the Human Ubiquitin C Promoter Reveals Heat Shock Element Architectures with Activating and Repressive Functions 370
Ubiquitin C gene: Structure, function, and transcriptional regulation 343
Dynamic transcription of ubiquitin genes under basal and stressful conditions and new insights into the multiple UBC transcript variants 330
Ubiquitin over-expression promotes E6AP autodegradation and reactivation of the p53/MDM2 pathway in HeLa cells 328
Nano-Mechanical Characterization of Ataxia Telangiectasia Cells Treated with Dexamethasone 315
Label-free quantification of activated NF-kB in biological samples by atomic force microscopy 311
A negative feedback mechanism links UBC gene expression to ubiquitin levels by affecting RNA splicing rather than transcription. 292
Transcription factor decoy oligonucleotides modified with locked nucleic acids: an in vitro study to reconcile biostability with binding affinity 285
A potent enhancer element in the 5'-UTR intron is crucial for transcriptionalregulation of the human ubiquitin C gene 285
A recombinant human 'mini'-hexokinase is catalytically active and regulated by hexose 6-phosphates 285
Dexamethasone improves redox state in ataxia telangiectasia cells by promoting an NRF2-mediated antioxidant response 282
Forward subtractive libraries containing genes transactivated by dexamethasone in ataxia-telangiectasia lymphoblastoid cells 274
A NONLINEAR THREE-COMPARTMENT MODEL FOR THE ADMINISTRATION OF 2’, 3’- DIDEOXYCYTIDINE BY USING RED BLOOD CELLS AS BIOREACTORS 273
Dexamethasone partially rescues ataxia telangiectasia-mutated (ATM) deficiency in ataxia telangiectasia by promoting a shortened protein variant retaining kinase activity. 270
Dehydroascorbic acid irreversibly inhibits hexokinase activity. 267
Immunophilin-loaded erythrocytes as a new delivery strategy for immunosuppressive drugs 266
Locked nucleic acids (LNA): versatile tools for designing oligonucleotide decoys with high stability and affinity 263
Expression, purification, and characterization of a recombinant erythroid-specific hexokinase isozyme 262
De-ubiquitylation is the most critical step in the ubiquitin mediated homeostatic control of the NF-kB/IKK basal activity 262
Oxidized ultrashort nanotubes as carbon scaffolds for the construction of cell-penetrating NF-kappaB decoy molecules 260
Resveratrol fuels HER2 and ERα-positive breast cancer behaving as proteasome inhibitor 253
Comparison of uricase-bound and uricase-loaded erythrocytes as bioreactors for uric acid degradation. 246
Activation of NRF2 by dexamethasone in ataxia telangiectasia cells involves KEAP1 inhibition but not the inhibition of p38 244
Comparison of uricase-bound and uricase-loaded erythrocytes as bioreactors for uric acid degradation 243
Design and characterization of decoy oligonucleotides containing locked nucleic acids 243
Drug delivery systems 235
2',3'- Dideoxycytidine permeation of the human erythrocyte membrane. 233
The Ubiquitin Gene Expression Pattern and Sensitivity to UBB and UBC Knockdown Differentiate Primary 23132/87 and Metastatic MKN45 Gastric Cancer Cells 232
Acetaldehyde dehydrogenase-loaded erythrocytes as bioreactors for the removal of blood acetaldehyde 231
Human red blood cells as bioreactors for the release of 2', 3'-dideoxycytidine, an inhibitor of HIV infectivity. 228
Efficient inhibition of macrophage TNF-alpha production upon targeted delivery of K48R ubiquitin 226
Binding of non-catalytic ATP to human hexokinase I highlights the structural components for enzyme-membrane association control. 225
Identification of blood erythroid markers useful in revealing erythropoietin abuse in athletes 219
High-level expression and purification of a human "mini"-hexokinase 211
Human hexokinase type I microheterogeneity is due to different amino-terminal sequences 209
Cloning and expression of a new human polypeptide which regulates protein phosphorylation in Escherichia coli 209
Hexokinase 208
DOWNREGULATION OF NITRIC OXIDE FORMATION BY CYTOSOLIC PHOSPHOLIPASE A2-RELEASED ARACHIDONIC ACID. 207
Activation of the ubiquitin proteolytic system in murine acquired immunodeficiency syndrome affects IkB-alpha turnover 206
Red Blood Cell Membrane Processing for Biomedical Applications 204
Overexpression of wild-type ubiquitin downregulates transcription of endogenous polyubiquitin genes in HeLa cells 203
The ubiquitin-dependent proteolytic system and other potential targets for the modulation of nuclear factor-kB (NF-kB) 201
Structural determinants that make hexokinase susceptible to ubiquitin- and ATP-dependent proteolysis 199
Human red blood cells as bioreactors for the release of 2',3'-dideoxycytidine, an inhibitor of HIV infectivity. 195
Human red blood cells as bioreactors for the release of 2',3'-dideoxycytidine, an inhibitor of HIV infectivity 194
Genomic DNA in human blastocoele fluid 192
A new humanized antibody is effective against pathogenic fungi in vitro 192
Role and mechanism of hexokinase decay during reticulocyte maturation and cell aging 191
Monitoring erythropoietin abuse in athletes 189
In vivo accelerated acetaldehyde metabolism using acetaldehyde dehydrogenase-loaded erythrocytes 187
REVERSED-PHASE LIQUID CHROMATOGRAPHIC DETERMINATION OF 2’, 3’-DIDEOXYCYTIDINE IN HUMAN BLOOD SAMPLES 187
Normalization of hyperglycemia in diabetic mice by enzyme-loaded erythrocytes 187
Expression, purification and preliminary crystallographic studies of human hexokinase I 187
ALCUNE PROPRIETÀ DI GLOBULI ROSSI UMANI SOTTOPOSTI A DIALISI IPOTONICA E RISIGILLAMENTO DA UTILIZZARE COME VEICOLI O BIOREATTORI. 185
Modulation of ICAM-1 expression in ECV304 cells by macrophage-released cytokines 185
Erythrocyte-mediated delivery of drugs, peptides and modified oligonucleotides 184
Molecular bases of hexokinase deficiency 181
Human hexokinase type I microheterogeneity is due to different amino-terminal 181
In vivo accelerated acetaldehyde metabolism using acetaldehyde dehydrogenase-loaded erythrocytes. 180
Drug-loaded red blood cells for the control of the inflammatory response: selective targeting of nuclear factor-kB (NF-kB) 177
Hexokinase mutations that produce nonspherocytic hemolytic anemia 174
Expression of hexokinase mRNA in human hippocampus 172
Improved metabolic properties of hexokinase-overloaded human erythrocytes 171
Modulation of NF-kB activation by targeted delivery of dexamethasone to macrophages 169
Ubiquitin overexpression leads to stabilization of p53 and increased p21 (CIP1/WAF1) transcription by promoting E6AP autodegradation in HeLa cells 169
Improved stability of 2,3-bisphosphoglycerate during storage of hexokinase-overloaded erythrocytes 166
Ubiquitin over-expression promotes E6AP degradation and reactivation of the p53/mdm-2 pathway 165
Dynamic changes in immunoproteasome assembly and capping with regulatory particles in an invitro model of senescing macrophages 162
Enzymatic properties of overexpressed human hexokinase fragments 162
LOCKED NUCLEIC ACIDS (LNA): VERSATILE TOOLS FOR DESIGNING OLIGONUCLEOTIDE DECOYS WITH HIGH STABILITY AND AFFINITY 158
FKBP12-loaded erythrocytes as a potential delivery system for the immunosuppressant Tacrolimus 158
Role of hexokinase in the regulation of erythrocyte hexose monophosphate pathway under oxidative stress 157
Localization and age-dependent expression of hexokinase mRNA in the rat brain 156
Ubiquitin-dependent regulation of E6AP protein levels 154
Design of decoys oligonucleotides stabilized by Locked Nucleic Acids. 153
Patterns of immunoproteasome subunit expression and assembly into proteolytic particles in gastric cancer cells with different histotypes: implications for cancer metastasis 151
Extraction and reversed-phase high-performance liquid chromatographic determination of 2',3'-dideoxycytidine from human blood samples. 150
Human red blood cell loading with hexokinase-inactivating antibodies. An in vitro model for enzyme deficiencies 148
Selective inhibition of NF-kB activation and TNF-alpha production in macrophages by red blood cell-mediated delivery of dexamethasone 146
Induction of ubiquitin C (UBC) gene transcription is mediated by HSF1: role of proteotoxic and oxidative stress 146
Engineering new metabolic pathways in isolated cells for the degradation of guanidinoacetic acid and simultaneous production of creatine. 146
Development and in vitro characterization of a humanized scFv against fungal infections 139
UbC trascription is modulated by a mechanism that senses ubiquitin pool dynamics. 138
Overexpression of ubiquitin downregulates transcription of the endogenous UbC gene in HeLa cells 136
Different intron-mediated enhancement mechanisms for the 5'-UTR intron of the human UbC gene 135
Role of heat shock transcription factors in the induction of UbC gene expression in MG132-treated cells 132
MOLECULAR BASES OF NONSPHEROCYTIC HEMOLYTIC ANEMIA DUE TO HEXOKINASE MUTATIONS 127
Efficient inhibition of macrophage TNF-alpha production by red cell mediated drug targeting 125
Engineered Red Blood Cells for the delivery and targeting of corticosteroid analogues 121
Modulation of macrophage activation by red cell-mediated drug targeting 121
Red blood cell loading with hexokinase and hexokinase-inactivating antibodies. A new strategy for studying the role of enzymes in red cell metabolism and removal 119
Extraction and reversed-phase high-performance liquid chromatographic determinaton of 2',3'-dideoxycytidine from human blood samples. 117
Molecular mechanism involved in glucocorticoid analogue action in Ataxia Telangiectasia: diferrentially expressed genes in AT cell lines in response to Dexamethasone 117
INCREASED GLUCOSE CONSUMPTION BY HUMAN AND MICE ERYTHROCYTES OVERLOADED WITH HEXOKINASE AND GLUCOSE OXIDASE. 116
Transgene-derived wild-type and mutant ubiquitin affects both proteolysis and transcription in HeLa cells. 116
Preclinical and clinical developments in enzyme-loaded red blood cells: an update 116
Dexamethasone effects in Ataxia Telangiectasia cell metabolism. 111
Totale 20.713
Salva come PNG Salva come JPEG
Categoria #
all - tutte 70.005
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.005
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021502 0 0 0 0 0 0 0 0 0 164 230 108
2021/20221.087 80 97 119 152 36 44 49 60 91 71 29 259
2022/20231.688 198 90 28 179 164 341 1 153 311 71 97 55
2023/2024815 51 42 16 78 26 118 22 298 8 69 7 80
2024/20252.062 106 94 420 135 62 116 256 94 227 154 204 194
2025/20264.267 502 372 511 853 487 333 564 118 278 249 0 0
Totale 21.530